In pancreatic cancer, PRMT3 enhances chemoresistance by methylating heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which stabilizes ABCG2 mRNA [24]. The gene discussed is HNRNPA1; the disease is familial pancreatic carcinoma.